Dow Up0.11% Nasdaq Up0.50%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE
117.30 Up 0.44(0.38%) Aug 29, 4:02PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2009Dec 31, 2008Dec 31, 2007
Assets
Current Assets
Cash And Cash Equivalents68,080  199,582  309,365  
Short Term Investments13,785  19,193  52,122  
Net Receivables251,860  160,688  230,048  
Inventory105,900  72,972  181,424  
Other Current Assets16,589  17,605  21,713  
Total Current Assets 456,214   470,040   794,672  
Long Term Investments -   -   -  
Property Plant and Equipment126,811  90,228  116,376  
Goodwill195,350  114,634  80,346  
Intangible Assets470,346  467,795  401,575  
Accumulated Amortization -   -   -  
Other Assets19,121  29,805  35,343  
Deferred Long Term Asset Charges37,637  14,850  65,950  
Total Assets 1,305,479   1,187,352   1,494,262  
Liabilities
Current Liabilities
Accounts Payable261,061  275,638  199,196  
Short/Current Long Term Debt48,462  666  1,655  
Other Current Liabilities21,612  15,893  4,810  
Total Current Liabilities 331,135   292,197   205,661  
Long Term Debt552,127  447,862  782,552  
Other Liabilities30,195  228,821  86,609  
Deferred Long Term Liability Charges20,843  15,047  5,337  
Minority Interest20   -   -  
Negative Goodwill -   -   -  
Total Liabilities 934,320   983,927   1,080,159  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock774  818  893  
Retained Earnings(642,043)(883,273)(859,559)
Treasury Stock -   -   -  
Capital Surplus986,393  1,067,758  1,192,559  
Other Stockholder Equity26,035  18,122  80,210  
Total Stockholder Equity 371,159   203,425   414,103  
Net Tangible Assets (294,537) (379,004) (67,818)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.